MASSOUD G DEZFULI D.O. NPI 1598861866

NPI Details

Massoud G Dezfuli, D.O. is an infectious disease internal medicine in Rancho Mirage, CA with 36 years of experience. The provider is an internist who deals with infectious diseases of all types and in all organ systems. Conditions requiring selective use of antibiotics call for this special skill. This physician often diagnoses and treats AIDS patients and patients with fevers which have not been explained. Infectious disease specialists may also have expertise in preventive medicine and travel medicine. Massoud G Dezfuli, D.O. NPI is 1598861866. The provider is registered as an individual entity type.

The NPPES NPI record indicates the provider is a male.

Education
Medical School: COLLEGE OF OSTEO MED OF THE PACIFIC AT POMONA
Graduation Year:1990

The provider's business location address is:

39700 BOB HOPE DR
SUITE 108
RANCHO MIRAGE, CA
ZIP 92270-267
Phone: (760) 834-3545
Fax: (760) 834-3546

The NPI 1598861866 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.

The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.

• Sarscov2 vac 30 mcg trs-sucr (HCPCS:91305)
• Adm sarscv2 30mcg trs-sucr b (HCPCS:0054A)
• Adm sarscov2 50mcg/0.25mlbst (HCPCS:0064A)
• Sarscov2 vac 50mcg/0.25ml im (HCPCS:91306)
• Administration of influenza virus vaccine (HCPCS:G0008)
• Influenza vaccine, quadrivalent, preservative free, 0.5 ml dosage (HCPCS:90686)
• Follow-up hospital inpatient care per day, typically 25 minutes (HCPCS:99232)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 30 mcg/0.3ml dosage, diluent reconstituted, for intramuscular use (HCPCS:91300)
• Adm sarscov2 30mcg/0.3ml 3rd (HCPCS:0003A)
• Coronavirus vaccine 14 (HCPCS:91313)
• Fee covid-19 vac 14 res (HCPCS:0134A)
• Coronavirus vaccine 13 (HCPCS:91312)
• Fee covid-19 vac 13 res (HCPCS:0124A)
• Initial hospital inpatient care per day, typically 50 minutes (HCPCS:99222)
• Established patient office or other outpatient visit, 30-39 minutes (HCPCS:99214)
• Follow-up hospital inpatient care per day, typically 35 minutes (HCPCS:99233)
• Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage (HCPCS:90694)
• Adm sarscv2 30mcg trs-sucr 1 (HCPCS:0051A)
• Adm sarscv2 30mcg trs-sucr 2 (HCPCS:0052A)
• New patient office or other outpatient visit, 45-59 minutes (HCPCS:99204)
• Severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage, for intramuscular use (HCPCS:91301)
• Initial hospital inpatient care per day, typically 70 minutes (HCPCS:99223)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; first dose (HCPCS:0011A)
• Intramuscular administration of single severe acute respiratory syndrome coronavirus 2 (covid-19) vaccine, mrna-lnp, spike protein, preservative free, 100 mcg/0.5ml dosage; second dose (HCPCS:0012A)

The enumeration date for this NPI number is 9/15/2006 and was last updated on 2/25/2016.

Taxonomy Codes

The NPI record includes the healthcare provider taxonomy classification, state license number and state of licensure. The following information regarding the scope of practice of this provider is available:

Other Identifiers

The following information regarding additional identifiers associated to this NPI record includes the other identifier number, identifier type, identifier state and issuer.